Evaluation of heart fatty acid‐binding protein as a biomarker for canine leishmaniosis
Veterinary Record · 20.05.2023 · 192 (10)
DOI: 10.1002/vetr.2683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 08.02.2023. Verfasst von Domingo Casamián-Sorrosal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Teaching Hospital & Department of Animal Medicine and Surgery, School of Veterinary Science, Universidad Católica de Valencia San Vicente …. Hauptthemen laut MEDLINE: Dog Diseases, Leishmania infantum, Leishmaniasis, Leishmaniasis, Visceral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
Background
Myocarditis frequently occurs in canine leishmaniosis (CanL). Heart fatty acid‐binding protein (HFABP) is a biomarker of myocardial damage.
Methods
This study aimed to compare HFABP concentration (HFABPc) in healthy dogs and dogs at different stages of CanL and evaluate the correlation of this biomarker with several clinicopathological and echocardiographic variables. Thirty‐one dogs diagnosed with CanL and 10 healthy dogs were included.
Results
HFABPc was not statistically different ( p > 0.05) between groups of dogs at different LeishVet stages of CanL or between groups with high versus low to intermediate serology titres. In 70% of CanL dogs, HFABPc was within the 95% confidence interval limits of the mean of healthy dogs. A moderate negative correlation with globulin ( r = −0.519; p = 0.03) and haematocrit (HCT) ( r = −0.538; p = 0.02) was observed. No other significant correlation ( p > 0.05) was observed with any other variable.
Limitations
Many statistical tests were performed, and therefore, type I error cannot be ruled out.
Conclusion
HFABPc is not consistently elevated in dogs with CanL and is not associated with the severity of the disease, or most echocardiographic or clinicopathological variables studied. The correlation with globulin and HCT was not strong and not considered clinically significant. HFABPc lacks sufficient predictive capacity in dogs with CanL, discouraging further research or clinical use of this biomarker in this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Veterinary Teaching Hospital & Department of Animal Medicine and Surgery, School of Veterinary Science, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain.
- Department of Animal Medicine & LeishmanCeres Laboratory, Faculty of Veterinary Science, Universidad de Extremadura, Caceres, Spain.
- Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
- Department of Animal Medicine and Surgery & Teaching Veterinary Hospital, Veterinary School, Universidad de Murcia, Murcia, Spain.
- Department of Animal Health & Veterinary Teaching Hospital, Universidad Complutense de Madrid, Madrid, Spain.
- Department of Animal Medicine and Surgery & Veterinary Teaching Hospital, Universidad Complutense de Madrid, Madrid, Spain.
ORCID-Profile: Domingo Casamián-Sorrosal, Silvia Belinchón-Lorenzo, Francisco Javier Duque
Zitieren
APA
Casamián-Sorrosal, D., Barrera-Chacón, R., Fonfara, S., Cristobal-Verdejo, J. I., Talavera-López, J., Belinchón-Lorenzo, S., Miró-Corrales, G., Caro-Vadillo, A., & Duque, F. J. (2023). Evaluation of heart fatty acid‐binding protein as a biomarker for canine leishmaniosis. Veterinary Record, 192(10). https://doi.org/10.1002/vetr.2683
Vancouver
Casamián-Sorrosal D, Barrera-Chacón R, Fonfara S, Cristobal-Verdejo JI, Talavera-López J, Belinchón-Lorenzo S, et al. Evaluation of heart fatty acid‐binding protein as a biomarker for canine leishmaniosis. Veterinary Record. 2023;192(10). doi:10.1002/vetr.2683
BibTeX
@article{CasaminSorrosal2023,
author = {Casamián-Sorrosal, Domingo and Barrera-Chacón, Rafael and Fonfara, Sonja and Cristobal-Verdejo, José Ignacio and Talavera-López, Jesús and Belinchón-Lorenzo, Silvia and Miró-Corrales, Guadalupe and Caro-Vadillo, Alicia and Duque, Francisco Javier},
title = {Evaluation of heart fatty acid‐binding protein as a biomarker for canine leishmaniosis},
journal = {Veterinary Record},
year = {2023},
volume = {192},
number = {10},
doi = {10.1002/vetr.2683}
}
EUVIMED